This website uses cookies This website uses cookies to store and access information to improve user experience and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. You consent to our cookies if you continue to use our website. OK Necessary Preferences Statistics Marketing Show details INTERNATIONAL | U.S. Careers Contact Us About us Products News, Press & Events VERYAN DESIGN INTELLIGENCE: imagination + intuition + innovation Our Vision 'We exist to improve patient care and quality of life through imagination, intuition and innovation' Our Purpose ‘Transforming lives through design intelligence’ BioMimics-3D® Vascular Stent System The BioMimics-3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery. Read more MIMICS-2 3-year data released Professor Thomas Zeller PI of the MIMICS-2 IDE study has announced that the freedom from CDTLR at 3 years for the BioMimics 3D stent was 81%, which is comparable to the outcomes for DCB, DES and Supera, despite treating more challenging lesions and without the need for lesion preparation. Read more Veryan & Otsuka Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London. Read more The Latest from Veryan News, updates and press releases Veryan & Otsuka Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co., Ltd., announced today that the BioMimics 3D Vascular Stent System is now available in Japan. Read more Veryan Medical announces multimillion-euro investment in Galway operation 6th April 2021 - Veryan has announced a multimillion-euro investment at its Galway facility that will contribute to the further expansion and diversification of Veryan’s product portfolio beyond the BioMimics 3D Swirling Flow stent. Read more First patient enrolment in MIMICS 3D USA 16th Dec 2020 - Veryan Medical (Horsham, UK) is delighted to announce that the first patient was enrolled today in the MIMICS-3D USA study by John H. Rundback MD at NJ Endovascular & Amputation Prevention, NJ. Read more Get in touch Find contact details and send us a message. Contact us TERMS & CONDITIONS PRIVACY AND COOKIES UK TAX STATEMENT About us Who we are Where we're going Our innovative approach Veryan people Careers Products BioMimics 3D® Vascular Stent System News, Press & Events News Press Releases Events ©Veryan Medical 2021 The BioMimics 3D Vascular Stent System has FDA and CE Mark approval. BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited. Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies. CAUTION: Federal law restricts this device to sale by or on the order of a physician.